{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:38:56Z","timestamp":1791268736740,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1124\/dmd.114.062901","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T14:40:07Z","timestamp":1427985607000},"page":"898-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Biodistribution of Etanercept to Tissues and Sites of Inflammation in Arthritic Rats"],"prefix":"10.1016","volume":"43","author":[{"given":"Xi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra C","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R","family":"Almon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.114.062901_bib1","doi-asserted-by":"crossref","first-page":"024017","DOI":"10.1117\/1.2717137","article-title":"Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer","volume":"12","author":"Adams","year":"2007","journal-title":"J Biomed Opt"},{"key":"10.1124\/dmd.114.062901_bib2","first-page":"1517","article-title":"Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice","volume":"54","author":"Baxter","year":"1994","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.114.062901_bib3","first-page":"H599","article-title":"Extravascular distribution of albumin and IgG during high-permeability edema in skin","volume":"244","author":"Bell","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.114.062901_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02276064","article-title":"Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669\/ RP 54476)","volume":"13","author":"Bernard","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1124\/dmd.114.062901_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01062191","article-title":"Physiologic modeling of cyclosporin kinetics in rat and man","volume":"19","author":"Bernareggi","year":"1991","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.114.062901_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/rheumatology\/31.5.293","article-title":"TNF alpha\u2014a pivotal role in rheumatoid arthritis?","volume":"31","author":"Brennan","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1124\/dmd.114.062901_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10928-013-9332-2","article-title":"Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies","volume":"40","author":"Cao","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.114.062901_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002280050117","article-title":"Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine","volume":"50","author":"Chosidow","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.114.062901_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.114.062901_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2191-219X-1-31","article-title":"Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets","volume":"1","author":"Cohen","year":"2011","journal-title":"EJNMMI Res"},{"key":"10.1124\/dmd.114.062901_bib11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1124\/dmd.114.060319","article-title":"Evaluation of near infrared fluorescent labeling of monoclonal antibodies as a tool for tissue distribution","volume":"42","author":"Conner","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.062901_bib12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2165\/00003495-200262170-00013","article-title":"Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis","volume":"62","author":"Culy","year":"2002","journal-title":"Drugs"},{"key":"10.1124\/dmd.114.062901_bib13","series-title":"Adapt 5 User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software","author":"D\u2019Argenio","year":"2009"},{"key":"10.1124\/dmd.114.062901_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1124\/jpet.108.137372","article-title":"Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats","volume":"326","author":"Earp","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.062901_bib15","first-page":"469","article-title":"Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions","volume":"23","author":"Edrees","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1124\/dmd.114.062901_bib16","series-title":"Investigation of the Role of Fcrn in the Absorption, Distribution, and Elimination of Monoclonal Antibodies","first-page":"334","author":"Garg","year":"2007"},{"key":"10.1124\/dmd.114.062901_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00446949","article-title":"Suction blister fluid as a model for interstitial fluid in rats","volume":"263","author":"Herfst","year":"1978","journal-title":"Arch Dermatol Res"},{"key":"10.1124\/dmd.114.062901_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/BIP-100104199","article-title":"Comments on Nedelman and Jia\u2019s extension of Satterthwaite\u2019s approximation applied to pharmacokinetics","volume":"11","author":"Holder","year":"2001","journal-title":"J Biopharm Stat"},{"key":"10.1124\/dmd.114.062901_bib19","first-page":"88","article-title":"Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon","volume":"73","author":"Hopkins","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/dmd.114.062901_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/jid.1968.15","article-title":"Suction blister device for separation of viable epidermis from dermis","volume":"50","author":"Kiistala","year":"1968","journal-title":"J Invest Dermatol"},{"key":"10.1124\/dmd.114.062901_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1345\/aph.19126","article-title":"The pharmacokinetics of etanercept in healthy volunteers","volume":"34","author":"Korth-Bradley","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.114.062901_bib22","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s11095-011-0396-7","article-title":"Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis","volume":"28","author":"Lon","year":"2011","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.114.062901_bib23","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/dmd.114.062901_bib24","first-page":"53","article-title":"New insight into the clinical pharmacokinetics of cefaclor: tissue penetration","volume":"12","author":"Mazzei","year":"2000","journal-title":"J Chemother"},{"key":"10.1124\/dmd.114.062901_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10543409808835241","article-title":"An extension of Satterthwaite\u2019s approximation applied to pharmacokinetics","volume":"8","author":"Nedelman","year":"1998","journal-title":"J Biopharm Stat"},{"key":"10.1124\/dmd.114.062901_bib26","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s40265-014-0258-9","article-title":"Etanercept: a review of its use in autoimmune inflammatory diseases","volume":"74","author":"Scott","year":"2014","journal-title":"Drugs"},{"key":"10.1124\/dmd.114.062901_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","article-title":"Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human","volume":"39","author":"Shah","year":"2012","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.114.062901_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/mabs.23684","article-title":"Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human","volume":"5","author":"Shah","year":"2013","journal-title":"MAbs"},{"key":"10.1124\/dmd.114.062901_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1208\/s12248-009-9157-5","article-title":"Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease","volume":"12","author":"Tabrizi","year":"2010","journal-title":"AAPS J"},{"key":"10.1124\/dmd.114.062901_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0026-2862(79)90017-7","article-title":"Dynamics of capillary fluid exchange: a nonlinear computer simulation","volume":"18","author":"Wiederhielm","year":"1979","journal-title":"Microvasc Res"},{"key":"10.1124\/dmd.114.062901_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1208\/s12248-012-9342-9","article-title":"Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice","volume":"14","author":"Wu","year":"2012","journal-title":"AAPS J"},{"key":"10.1124\/dmd.114.062901_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0091270004273321","article-title":"Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein","volume":"45","author":"Zhou","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.114.062901_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0091270010375961","article-title":"Integrated population pharmacokinetics of etanercept in healthy subjects and in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"51","author":"Zhou","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.114.062901_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11307-014-0773-9","article-title":"IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques","volume":"17","author":"Zinn","year":"2015","journal-title":"Mol Imaging Biol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624103182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624103182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.114.062901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:27:31Z","timestamp":1739906851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624103182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0090955624103182"],"URL":"https:\/\/doi.org\/10.1124\/dmd.114.062901","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodistribution of Etanercept to Tissues and Sites of Inflammation in Arthritic Rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.114.062901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}